1.0000
+0.0854
+(9.34%)
At close: April 9 at 4:00:02 PM EDT
0.9802
-0.02
(-1.98%)
After hours: April 9 at 7:40:22 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-130,873
-130,873
-166,522
-98,771
-38,650
Investing Cash Flow
-15,506
-15,506
100,940
-74,931
-214,365
Financing Cash Flow
122,115
122,115
53,329
167,772
323,551
End Cash Position
28,235
28,235
52,554
64,819
70,791
Income Tax Paid Supplemental Data
--
--
--
--
3
Capital Expenditure
-241
-241
-514
-275
-262
Issuance of Capital Stock
121,649
121,649
48,408
165,398
323,036
Issuance of Debt
--
--
--
--
450
Free Cash Flow
-131,114
-131,114
-167,036
-99,046
-38,912
12/31/2021 - 10/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASMB Assembly Biosciences, Inc.
8.63
+4.48%
SPRO Spero Therapeutics, Inc.
0.5899
+5.34%
EPIX ESSA Pharma Inc.
1.5200
+3.40%
KROS Keros Therapeutics, Inc.
10.33
+5.84%
HLVX HilleVax, Inc.
1.5400
+5.48%
RPTX Repare Therapeutics Inc.
0.9300
-2.11%
CLRB Cellectar Biosciences, Inc.
0.2457
+2.12%
THRD Third Harmonic Bio, Inc.
3.5000
+1.45%
GLTO Galecto, Inc.
2.4400
+8.93%
IPSC Century Therapeutics, Inc.
0.4185
+7.56%